ORAGENICS INC cotiza a 0.45 USD y tiene una capitalización bursátil de $2M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Oragenics, Inc., a development-stage company, engages in the research and development of nasal delivery pharmaceutical therapies neurological conditions and infectious diseases in the United States. Its lead product is ONP-002, a fully synthetic, non-naturally occurring neurosteroid, which is lipophilic and can cross t…
| Periodo | 2023-05 | 2023-04 | 2022-11 | 2022-08 |
|---|---|---|---|---|
| Real | $-42.30 | $-16.20 | $-54.01 | $-54.01 |
| Estimado | $-90.01 | $-72.01 | $-90.01 | $-72.01 |
| Sorpresa | +53.0% | +77.5% | +40.0% | +25.0% |
| Métrica | OGEN | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | — | -38.6% | — |
| Net Margin | — | -33.6% | — |
| FCF Margin | — | -13.9% | — |
| ROE | -118.8% | -40.4% | -78.4% |
| ROA | -97.8% | -32.0% | -65.8% |
| Current Ratio | — | 2.84 | — |
| Debt / Equity | — | 0.28 | — |